Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amine Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110003061B reveals a novel iron-catalyzed direct amination method. This technology offers significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN1680332A details a high-yield route for amine derivatives inhibiting amyloid beta. Offers industrial advantages for pharmaceutical intermediate manufacturing.
Patent CN106715392A reveals low temperature glucoprotamine production enabling cost reduction and supply chain reliability for high purity chemical manufacturing partners.
Patent CN113166183B reveals a novel iridium process for high-purity hydroxylamine synthesis, offering significant cost reduction and supply chain reliability for complex intermediates.
Patent CN103739417A details a green aqueous copper-catalyzed amination. Offers cost reduction in pharmaceutical intermediate manufacturing with recyclable systems.
Patent CN101747208A details a novel synthesis for non-conjugated fluorene-triphenylamine derivatives, offering enhanced thermal stability and simplified manufacturing for display materials.
Patent CN114276286A reveals a novel one-pot synthesis of N,N-disubstituted-alpha,beta-unsaturated enamines using DMSO and base, offering significant cost reduction in API manufacturing.
Patent CN1215045C discloses high-purity crystalline salts of 3,3-diphenylpropylamine derivatives, offering superior stability and bioavailability for urinary incontinence treatments.
Patent CN102391149B details a zero-wastewater method for N,N-dibenzylhydroxylamine. Enhances yield and purity for polymer additives manufacturing.
Patent CN112920114B reveals a novel 3-step catalytic synthesis for hydroxychloroquine sulfate, eliminating toxic phenol solvents and high-pressure risks for cost-effective manufacturing.
Patent CN109134267B discloses a metal-free route to aromatic amines from alkyl aromatics. Offers significant cost reduction and scalability for API manufacturing.
Discover the metal-free synthesis of aromatic amines via patent CN109134267A. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Novel iodine-catalyzed oxidative sulfonylation method for high-purity pharmaceutical intermediates with reduced costs and scalable production capabilities.
Discover the advanced synthesis of N-substituted-3-(benzenesulfonyl)quinoxaline-2-amines via patent CN101602737B, offering cost-effective routes for oncology drug development.
Advanced sulfonation-methylation route for N,N'-dimethyl cyclohexanediamine. Eliminates hazardous LiAlH4 reduction, ensuring >98% purity and safer industrial scale-up.
Advanced 3-step synthesis of naphthoyl amine derivatives for kinase inhibitors. Reliable pharmaceutical intermediate supplier offering cost-effective, scalable routes.
Novel oleum-based process for thioalkylamines eliminates evaporation steps. High space-time yield and scalable route for pharmaceutical intermediates manufacturing.
Novel cuprous complex catalyst enables room temperature Buchwald-Hartwig coupling for high-purity pharmaceutical intermediates with reduced costs.
Patent CN104844498B reveals efficient titanocene catalysis. Offers supply chain stability and cost reduction for pharmaceutical intermediate manufacturing globally.
Patent CN104262167B reveals a mild metal phthalocyanine catalytic route for diarylamines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.